“Stereotactic Radiotherapy in Combination with the Immunoconjugate Trastuzumab Emtansine in Patients with HER2-Positive Oligometastatic Breast Cancer: Final Results of the Efficacy and Safety Study”, Вопр. онкол., vol. 72, no. 3, p. OF-2696, Jul. 2026, doi: 10.37469/0507-3758-2026-72-3-OF-2696.